Know Cancer

forgot password

Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer

Phase 2
18 Years
Open (Enrolling)
Cervical Cancer

Thank you

Trial Information

Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer

Inclusion Criteria:

- Patient with cervical carcinoma: histological proof of epidermoid carcinoma or of

- Stage I to IV (limited to pelvic) (FIGO Classification) (see appendix 3)

- Age ≥ 18 years old

- No contra-indication to surgery

- Dated, informed and signed consent from the patient

Exclusion Criteria:

- Metastatic cervical cancer with extra-pelvic metastasis

- Contra-indication to MRI: implantation of an electronic device, metallic or
ferromagnetic foreign body

- Serious co-existing affection with vital prognosis

- Diabetes uncontrolled by a classical treatment: glycaemia > 1.4g/l

- Pregnancy and lactation

- Uncontrolled infection

- Other cancer within the previous 5 years, except skin basal cell carcinoma, or in
situ cervical cancer

- Patient with some deficiency preventing her from completely understanding any
requirement of the study, which might compromise the patient's consent and/or the
observance of the protocol and the consistent participation to the study.

Type of Study:


Study Design:

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Estimation of the pelvic and/or para-aortic lymph node involvement with the PET, in comparison with the MRI and the histological results of node dissection.

Principal Investigator

Dominique GENET, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Hospital, Limoges


France : DGS

Study ID:




Start Date:

October 2003

Completion Date:

Related Keywords:

  • Cervical Cancer
  • PETscan, cervical cancer
  • Uterine Cervical Neoplasms